Skip to main content

Maria Pilar Delgado Martínez

Institutions of which they are part

Main researcher
Neurovascular Diseases
Vall Hebron Institut de Recerca

Maria Pilar Delgado Martínez

Institutions of which they are part

Main researcher
Neurovascular Diseases
Vall Hebron Institut de Recerca

Projects

Participación de sistemas proteolíticos en la progresión de la angiopatía amiloide cerebral

IP: Mercè Boada Rovira
Collaborators: Francesc Pujadas Navinés, Maria Mar Hernandez Guillamon, Maria Pilar Delgado Martínez
Funding agency: Instituto de Salud Carlos III
Funding: 161535
Reference: PI070737
Duration: 01/01/2008 - 30/06/2011

RENEVAS - Red de Investigación Cooperativa Neurovascular

IP: Joan Montaner Villalonga
Collaborators: Marta Aurora Rubiera Del Fueyo, José Alvarez Sabin, Anna Penalba Morenilla, Maria Mar Hernandez Guillamon, RENEVAS - Red de Investigación Cooperativa Neurovascular, Marc Ribó Jacobi, Maria Pilar Delgado Martínez, Carlos Molina Cateriano, Anna Rosell Novel, Estevo Santamarina Pérez, Manuel Quintana Luque
Funding agency: Instituto de Salud Carlos III
Funding: 793573.69
Reference: RD06/0026/0010
Duration: 02/01/2007 - 31/12/2013

Grup de Recerca en Malalties Neurovasculars

IP: Joan Montaner Villalonga
Collaborators: José Alvarez Sabin, Marc Ribó Jacobi, Maria Pilar Delgado Martínez, Carlos Molina Cateriano, Anna Rosell Novel, Estevo Santamarina Pérez, Manuel Quintana Luque
Funding agency: Agència Gestió Ajuts Universitaris i de Recerca
Funding: 50600
Reference: 2005SGR 00614
Duration: 01/01/2006 - 31/12/2008

Hemorragia cerebral en el adulto de edad avanzada

IP: Joan Montaner Villalonga
Collaborators: Maria Pilar Delgado Martínez
Funding agency: Instituto de Salud Carlos III
Funding:
Reference: CM05/00065
Duration: 18/01/2006 - 18/01/2009

Related news

The TOUCH MSCA-COFUND doctoral training programme, led by UAB and focusing on the field of mental health, has opened its first call for applications, offering 13 doctoral positions.

The Cardiovascular Diseases and Neurovascular Diseases groups at VHIR will investigate new therapeutic strategies for heart failure, nanomedicine in stroke and the prevention of cardiovascular toxicity in the case of oncological treatments.

La recerca és fonamental per contrarestar els efectes de la pol·lució, que segons l’AEMPS, va ser la causa de més de 300.000 morts prematures a la UE el 2020.

Related professionals

Patricia Hinojosa Casanova

Patricia Hinojosa Casanova

Auxiliar Tècnic Recerca - Infermer/a
General Services and Infrastructures Unit
Manager
Read more
Gemma Giralt García

Gemma Giralt García

Cardiovascular Diseases
Read more
Aroa  Gomez  Brey

Aroa Gomez Brey

Research technician
Donation and transplantation of organs, tissues and cells
Read more
Gemma Español Martín

Gemma Español Martín

Psychiatry, Mental Health and Addictions
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.